Cargando…
Membrane-wrapped nanoparticles for photothermal cancer therapy
Cancer is a global health problem that needs effective treatment strategies. Conventional treatments for solid-tumor cancers are unsatisfactory because they cause unintended harm to healthy tissues and are susceptible to cancer cell resistance. Nanoparticle-mediated photothermal therapy is a minimal...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373884/ https://www.ncbi.nlm.nih.gov/pubmed/35960404 http://dx.doi.org/10.1186/s40580-022-00328-4 |
_version_ | 1784767680164659200 |
---|---|
author | Aboeleneen, Sara B. Scully, Mackenzie A. Harris, Jenna C. Sterin, Eric H. Day, Emily S. |
author_facet | Aboeleneen, Sara B. Scully, Mackenzie A. Harris, Jenna C. Sterin, Eric H. Day, Emily S. |
author_sort | Aboeleneen, Sara B. |
collection | PubMed |
description | Cancer is a global health problem that needs effective treatment strategies. Conventional treatments for solid-tumor cancers are unsatisfactory because they cause unintended harm to healthy tissues and are susceptible to cancer cell resistance. Nanoparticle-mediated photothermal therapy is a minimally invasive treatment for solid-tumor cancers that has immense promise as a standalone therapy or adjuvant to other treatments like chemotherapy, immunotherapy, or radiotherapy. To maximize the success of photothermal therapy, light-responsive nanoparticles can be camouflaged with cell membranes to endow them with unique biointerfacing capabilities that reduce opsonization, prolong systemic circulation, and improve tumor delivery through enhanced passive accumulation or homotypic targeting. This ensures a sufficient dose of photoresponsive nanoparticles arrives at tumor sites to enable their complete thermal ablation. This review summarizes the state-of-the-art in cell membrane camouflaged nanoparticles for photothermal cancer therapy and provides insights to the path forward for clinical translation. |
format | Online Article Text |
id | pubmed-9373884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Nature Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-93738842022-08-12 Membrane-wrapped nanoparticles for photothermal cancer therapy Aboeleneen, Sara B. Scully, Mackenzie A. Harris, Jenna C. Sterin, Eric H. Day, Emily S. Nano Converg Review Cancer is a global health problem that needs effective treatment strategies. Conventional treatments for solid-tumor cancers are unsatisfactory because they cause unintended harm to healthy tissues and are susceptible to cancer cell resistance. Nanoparticle-mediated photothermal therapy is a minimally invasive treatment for solid-tumor cancers that has immense promise as a standalone therapy or adjuvant to other treatments like chemotherapy, immunotherapy, or radiotherapy. To maximize the success of photothermal therapy, light-responsive nanoparticles can be camouflaged with cell membranes to endow them with unique biointerfacing capabilities that reduce opsonization, prolong systemic circulation, and improve tumor delivery through enhanced passive accumulation or homotypic targeting. This ensures a sufficient dose of photoresponsive nanoparticles arrives at tumor sites to enable their complete thermal ablation. This review summarizes the state-of-the-art in cell membrane camouflaged nanoparticles for photothermal cancer therapy and provides insights to the path forward for clinical translation. Springer Nature Singapore 2022-08-12 /pmc/articles/PMC9373884/ /pubmed/35960404 http://dx.doi.org/10.1186/s40580-022-00328-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Aboeleneen, Sara B. Scully, Mackenzie A. Harris, Jenna C. Sterin, Eric H. Day, Emily S. Membrane-wrapped nanoparticles for photothermal cancer therapy |
title | Membrane-wrapped nanoparticles for photothermal cancer therapy |
title_full | Membrane-wrapped nanoparticles for photothermal cancer therapy |
title_fullStr | Membrane-wrapped nanoparticles for photothermal cancer therapy |
title_full_unstemmed | Membrane-wrapped nanoparticles for photothermal cancer therapy |
title_short | Membrane-wrapped nanoparticles for photothermal cancer therapy |
title_sort | membrane-wrapped nanoparticles for photothermal cancer therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373884/ https://www.ncbi.nlm.nih.gov/pubmed/35960404 http://dx.doi.org/10.1186/s40580-022-00328-4 |
work_keys_str_mv | AT aboeleneensarab membranewrappednanoparticlesforphotothermalcancertherapy AT scullymackenziea membranewrappednanoparticlesforphotothermalcancertherapy AT harrisjennac membranewrappednanoparticlesforphotothermalcancertherapy AT sterinerich membranewrappednanoparticlesforphotothermalcancertherapy AT dayemilys membranewrappednanoparticlesforphotothermalcancertherapy |